SCHEMBL2494170

SCHEMBL2494170

CCCCOP(=O)(OCC)c1c(-c2ccc(-c3cccs3)s2)sc(-c2ccc(-c3cccs3)s2)c1P(=O)(OCC)OCCCC

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.42
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 4/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
HDAC1 Q13547 2/20 0.35
MAPT P10636 2/20 0.35
LMNA P02545 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LTA4H P09960 1/20 0.33
HPGD P15428 2/20 0.33
TP53 P04637 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HRH2 P25021 1/20 0.32
HRH1 P35367 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12191767 0.96 DPP4 (0.42) DPP4KDM4EALDH1A1NPC1RAB9A
SCHEMBL2495901 0.92 DPP4 (0.40) DPP4KDM4EALDH1A1NPC1RAB9A
SCHEMBL2498942 0.92 DPP4 (0.40) DPP4KDM4EALDH1A1NPC1RAB9A
SCHEMBL2493159 0.92 DPP4 (0.40) DPP4KDM4EALDH1A1NPC1RAB9A
SCHEMBL2491472 0.92 DPP4 (0.49) DPP4KDM4EALDH1A1NPC1RAB9A
SCHEMBL2497371 0.92 DPP4 (0.49) DPP4KDM4EALDH1A1NPC1RAB9A
SCHEMBL12191889 0.91 DPP4 (0.37) DPP4KDM4EALDH1A1NPC1RAB9A
SCHEMBL2496787 0.90 DPP4 (0.48) DPP4KDM4EALDH1A1NPC1RAB9A
SCHEMBL12191771 0.90 DPP4 (0.48) DPP4KDM4EALDH1A1NPC1RAB9A
SCHEMBL2498947 0.88 DPP4 (0.43) DPP4KDM4EALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1882694-B1 OLIGOMERS AND POLYMERS OF THIOPHENE COMPOUNDS HAVING PHOSPHORIC ESTER AND PROCESS FOR PRODUCING THE SAME NISSAN CHEMICAL IND LTD (JP) 2013-04-03 EP disclosed
US-8030438-B2 Thiophene compound having phosphoric ester and process for producing the same NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2011-10-04 US disclosed
US-20100019229-A1 Thiophene compound having phosphoric ester and process for producing the same NISSAN CHEMICAL INDUSTRIES, LTD (JP) 2010-01-28 US disclosed
EP-1882694-A1 THIOPHENE COMPOUND HAVING PHOSPHORIC ESTER AND PROCESS FOR PRODUCING THE SAME Nissan Chemical Industries, Ltd. (JP) 2008-01-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100019229-A1 Thiophene compound having phosphoric ester and process for producing the same RRP12, NR2E1, TST DPP4 3787/4885KDM4E 3208/4885ALDH1A1 4083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.